TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-3.25%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.29B
AUM Growth
+$2.29B
(-6.5%)
Cap. Flow
-$54.6M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
41.8%
Holding
210
New
13
Increased
53
Reduced
57
Closed
18
Top Buys
| 1 |
Merck
MRK
|
$16.6M |
| 2 |
Illumina
ILMN
|
$13M |
| 3 |
Humana
HUM
|
$9.23M |
| 4 |
Biogen
BIIB
|
$7.74M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.28M |
Top Sells
| 1 |
Amgen
AMGN
|
$18.8M |
| 2 |
Abbott
ABT
|
$15.2M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$15M |
| 4 |
Thermo Fisher Scientific
TMO
|
$13.7M |
| 5 |
Eli Lilly
LLY
|
$10.8M |
Sector Composition
| 1 | Healthcare | 94.94% |
| 2 | Real Estate | 3.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $146M | 6.38% | 1,473,710 | – | – |
|
|
2
Amgen
AMGN
$155B
| $122M | 5.34% | 632,287 -97,371 | -13% | -$18.8M |
|
3
Gilead Sciences
GILD
$140B
| $116M | 5.07% | 1,833,982 -2,130 | -0.1% | -$135K |
|
4
Johnson & Johnson
JNJ
$427B
| $106M | 4.62% | 818,227 -71,777 | -8% | -$9.29M |
|
|
5
Merck
MRK
$210B
| $102M | 4.45% | 1,211,384 +197,689 | +20% | +$16.6M |
|
6
Vertex Pharmaceuticals
VRTX
$100B
| $82.5M | 3.6% | 487,234 -2,500 | -0.5% | -$424K |
|
7
Pfizer
PFE
$141B
| $76M | 3.31% | 2,114,306 +46,041 | +2% | +$1.65M |
|
|
8
Illumina
ILMN
$15.8B
| $73.4M | 3.2% | 241,139 +42,668 | +21% | +$13M |
|
9
UnitedHealth
UNH
$281B
| $73.3M | 3.2% | 337,283 +13,150 | +4% | +$2.86M |
|
|
10
Biogen
BIIB
$19.4B
| $60.1M | 2.62% | 257,939 +33,249 | +15% | +$7.74M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $44.5M | 1.94% | 453,887 +53,873 | +13% | +$5.28M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $44.3M | 1.93% | 159,658 -7,310 | -4% | -$2.03M |
|
13
Medtronic
MDT
$119B
| $43.4M | 1.89% | 399,370 -80,665 | -17% | -$8.76M |
|
14
Bristol-Myers Squibb
BMY
$96B
| $37.4M | 1.63% | 738,044 | – | – |
|
15
CVS Health
CVS
$92.8B
| $34.1M | 1.49% | 540,286 -35,115 | -6% | -$2.21M |
|
16
Zoetis
ZTS
$69.3B
| $31M | 1.35% | 249,024 +440 | +0.2% | +$54.8K |
|
17
AbbVie
ABBV
$372B
| $30.3M | 1.32% | 400,016 +66,700 | +20% | +$5.05M |
|
18
Intuitive Surgical
ISRG
$170B
| $30M | 1.31% | 55,475 -200 | -0.4% | -$108K |
|
19
Incyte
INCY
$16.5B
| $29.2M | 1.28% | 393,730 -117,203 | -23% | -$8.7M |
|
20
Elevance Health
ELV
$71.8B
| $29.1M | 1.27% | 121,132 +17,676 | +17% | +$4.24M |
|
|
21
Abbott
ABT
$231B
| $27M | 1.18% | 322,513 -181,635 | -36% | -$15.2M |
|
|
22
Thermo Fisher Scientific
TMO
$186B
| $26M | 1.13% | 89,310 -46,888 | -34% | -$13.7M |
|
23
Stryker
SYK
$150B
| $25.6M | 1.12% | 118,520 +15,570 | +15% | +$3.37M |
|
|
SGEN
24
DELISTED
Seagen Inc. Common Stock
SGEN
| $24.8M | 1.08% | 289,925 | – | – |
|
|
AGN
25
DELISTED
Allergan plc
AGN
| $24.4M | 1.07% | 145,281 +1,000 | +0.7% | +$168K |
|